<!DOCTYPE html>

<html lang="en"><head>
<meta content="text/html; charset=utf-8" http-equiv="content-type"/>
<meta charset="utf-8"/>
<meta content="IE=edge" http-equiv="X-UA-Compatible"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<title>Sample Reports</title>
<style>
    table {
      border-collapse: collapse;
      width: 100%;
    }

    th,
    td {
      border: 1px solid black;
      padding: 8px;
      text-align: left;
    }

    th {
      background-color: #f2f2f2;
    }

    tr:nth-child(even) {
      background-color: #f2f2f2;
    }

  </style>
</head>
<body><h1>MR CARDIAC</h1><table>
<tbody>
<tr><td bgcolor="#ababab">Free Text</td><td ,="" bgcolor="#ededed" style="white-space: word-wrap;">CLINICAL
 HISTORY: Evaluate for myocarditis COMPARISON: None. PROCEDURE: Field 
Strength: 3 T MRI Protocol Name: Cardiac Myocarditis Assessment Series 
Acquired: Axial T2-weighted imaging of the upper abdomen and the heart 
SAX &amp; Cine imagine of the heart in multiple planes. FINDINGS: Normal
 size of both ventricles. Mild global hypokinesis of the left ventricle 
is noted, with an ejection fraction of 48%. No significant segmental 
wall motion abnormality. No obvious valvular regurgitation. A small 
pericardial effusion is present. Late gadolinium enhancement (LGE) 
images demonstrate patchy areas of subepicardial enhancement in the 
lateral and inferolateral walls of the left ventricle, suggestive of 
myocardial inflammation. T2-weighted images reveal increased signal 
intensity in the lateral and inferolateral walls, consistent with 
myocardial edema. QUANTITATIVE MEASUREMENTS Biometrics: 75.5 kg, 170 cm,
 BSA 1.89 m^2 Volume Quantification: RVEDV: 135 mL, 71 mL/m^2 RVESV: 55 
mL, 29 mL/m^2 RVSV: 80 mL, 42 mL/m^2 RVEF: 59 % LVEDV: 180 mL, 95 mL/m^2
 LVESV: 93 mL, 49 mL/m^2 LVSV: 87 mL, 46 mL/m^2 LVEF: 48 % IMPRESSION: 
Findings suggestive of myocarditis with patchy areas of subepicardial 
enhancement in the lateral and inferolateral walls of the left 
ventricle, along with increased T2 signal intensity consistent with 
myocardial edema. Mild global hypokinesis of the left ventricle with an 
ejection fraction of 48%. Small pericardial effusion. RECOMMENDATIONS: 
Clinical correlation is advised to determine the relevance of these 
findings in relation to the patient's symptoms. Further evaluation and 
management of myocarditis should be discussed with the patient's 
healthcare provider, considering the patient's symptoms and physical 
examination findings. Follow-up cardiac MRI may be considered to monitor
 the resolution of myocardial inflammation and improvement of left 
ventricular function.</td></tr>
<tr><td bgcolor="#ababab">Structured</td><td ,="" bgcolor="#ffffff" style="white-space: pre-wrap; word-wrap: break-word;"><table border="1"><tbody><tr><th>CARDIACMRI</th><td>Cardiac Myocarditis Assessment</td></tr><tr><th>CLINICALINFORMATION</th><td>Evaluate for myocarditis</td></tr><tr><th>COMPARISON</th><td><table border="1"><tbody><tr><th>PRIORSTUDYDATE</th><td>None</td></tr></tbody></table></td></tr><tr><th>FINDINGS</th><td><table border="1"><tbody><tr><th>LEFTVENTRICULARMEASUREMENTS</th><td><table border="1"><tbody><tr><th>EJECTIONFRACTION</th><td><table border="1"><tbody><tr><th>VALUE</th><td>48</td></tr><tr><th>UNIT</th><td>%</td></tr><tr><th>NORMALRANGE</th><td><table border="1"><tbody><tr><th>MALE</th><td>56-78</td></tr><tr><th>FEMALE</th><td>56-78</td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><th>ENDDIASTOLICVOLUME</th><td><table border="1"><tbody><tr><th>VALUE</th><td>180</td></tr><tr><th>UNIT</th><td>mL</td></tr><tr><th>NORMALRANGE</th><td><table border="1"><tbody><tr><th>MALE</th><td>77-195</td></tr><tr><th>FEMALE</th><td>52-141</td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><th>INDEXEDENDDIASTOLICVOLUME</th><td><table border="1"><tbody><tr><th>VALUE</th><td>95</td></tr><tr><th>UNIT</th><td>mL/m2</td></tr></tbody></table></td></tr><tr><th>ENDSYSTOLICVOLUME</th><td><table border="1"><tbody><tr><th>VALUE</th><td>93</td></tr><tr><th>UNIT</th><td>mL</td></tr><tr><th>NORMALRANGE</th><td><table border="1"><tbody><tr><th>MALE</th><td>19-72</td></tr><tr><th>FEMALE</th><td>13-51</td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><th>INDEXEDENDSYSTOLICVOLUME</th><td><table border="1"><tbody><tr><th>VALUE</th><td>49</td></tr><tr><th>UNIT</th><td>mL/m2</td></tr></tbody></table></td></tr><tr><th>STROKEVOLUME</th><td><table border="1"><tbody><tr><th>VALUE</th><td>87</td></tr><tr><th>UNIT</th><td>ml</td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><th>RIGHTVENTRICULARMEASUREMENTS</th><td><table border="1"><tbody><tr><th>ENDDIASTOLICVOLUME</th><td><table border="1"><tbody><tr><th>VALUE</th><td>135</td></tr><tr><th>UNIT</th><td>mL</td></tr><tr><th>NORMALRANGE</th><td><table border="1"><tbody><tr><th>MALE</th><td>88-227</td></tr><tr><th>FEMALE</th><td>58-154</td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><th>INDEXEDENDDIASTOLICVOLUME</th><td><table border="1"><tbody><tr><th>VALUE</th><td>71</td></tr><tr><th>UNIT</th><td>mL/m2</td></tr></tbody></table></td></tr><tr><th>ENDSYSTOLICVOLUME</th><td><table border="1"><tbody><tr><th>VALUE</th><td>55</td></tr><tr><th>UNIT</th><td>mL</td></tr><tr><th>NORMALRANGE</th><td><table border="1"><tbody><tr><th>MALE</th><td>23-105</td></tr><tr><th>FEMALE</th><td>12-68</td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><th>INDEXEDENDSYSTOLICVOLUME</th><td><table border="1"><tbody><tr><th>VALUE</th><td>29</td></tr><tr><th>UNIT</th><td>mL/m2</td></tr></tbody></table></td></tr><tr><th>EJECTIONFRACTION</th><td><table border="1"><tbody><tr><th>VALUE</th><td>59</td></tr><tr><th>UNIT</th><td>%</td></tr><tr><th>NORMALRANGE</th><td><table border="1"><tbody><tr><th>MALE</th><td>47-74</td></tr><tr><th>FEMALE</th><td>47-80</td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><th>STROKEVOLUME</th><td><table border="1"><tbody><tr><th>VALUE</th><td>80</td></tr><tr><th>UNIT</th><td>ml</td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><th>OTHERFINDINGS</th><td><table border="1"><tbody><tr><th>PERICARDIALEFFUSION</th><td>Small</td></tr><tr><th>MYOCARDIALINFLAMMATION</th><td>Patchy areas of subepicardial enhancement in the lateral and inferolateral walls of the left ventricle</td></tr><tr><th>MYOCARDALEDEMA</th><td>Increased T2 signal intensity in the lateral and inferolateral walls</td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><th>IMPRESSION</th><td><table border="1"><tbody><tr><th>GLOBALSYSTOLICLVFUNCTION</th><td><table border="1"><tbody><tr><th>MILDLYIMPAIRED</th><td>Mildly impaired</td></tr></tbody></table></td></tr><tr><th>INTRACARDIACSHUNT</th><td><table border="1"><tbody><tr><th>NONE</th><td>None</td></tr></tbody></table></td></tr><tr><th>VALVULARDISEASE</th><td><table border="1"><tbody><tr><th>ABSENT</th><td>Absent</td></tr></tbody></table></td></tr><tr><th>MYOCARDITIS</th><td>Findings suggestive of myocarditis</td></tr></tbody></table></td></tr><tr><th>REFERENCE</th><td>American Journal of Roentgenology. 2014;203: 1265-1271. 10.2214/AJR.14.12636</td></tr></tbody></table></td></tr>
<tr><td bgcolor="#ababab">Free Text</td><td ,="" bgcolor="#ededed" style="white-space: word-wrap;">EXAMINATION:
 Cardiac MRI PATIENT HISTORY: A 65-year-old male with a history of 
hypertension and dyspnea on exertion. Evaluation for possible 
hypertrophic cardiomyopathy is requested. TECHNIQUE: 3 Tesla MRI 
scanner. The study includes cine imaging in standard long-axis and 
short-axis views, T2-weighted imaging, T2* imaging, late gadolinium 
enhancement (LGE) sequences, and volumetric quantification measurements.
 FINDINGS: The left ventricle demonstrates asymmetric septal hypertrophy
 with a maximal wall thickness of 18 mm in the basal anteroseptal 
segment. The left ventricular ejection fraction is preserved at 
approximately 55%. The right ventricle appears normal in size and 
function. Mild aortic regurgitation is observed, and the other valves 
appear normal. No significant pericardial effusion is identified. Late 
gadolinium enhancement reveals patchy mid-myocardial enhancement in the 
hypertrophied septal segments, suggestive of myocardial fibrosis. 
T2-weighted images show no signs of myocardial edema or inflammation. 
T2* imaging reveals a myocardial T2* value of 32 milliseconds, 
indicating no significant myocardial iron overload. The atria are normal
 in size, and no intracardiac thrombus is detected. Volumetric 
Measurements: Patient weight/height: 92 kg, 180 cm, BSA 2.18 m^2 RVEDV: 
156 mL, 72 mL/m^2 RVESV: 68 mL, 31 mL/m^2 RVSV: 88 mL, 40 mL/m^2 RVEF: 
56 % LVEDV: 193 mL, 89 mL/m^2 LVESV: 87 mL, 40 mL/m^2 LVSV: 106 mL, 49 
mL/m^2 LVEF: 55 % IMPRESSION: Asymmetric septal hypertrophy with maximal
 wall thickness of 18 mm in the basal anteroseptal segment, consistent 
with hypertrophic cardiomyopathy. Preserved left ventricular ejection 
fraction at 55%. Patchy mid-myocardial enhancement in the hypertrophied 
septal segments, suggestive of myocardial fibrosis. Mild aortic 
regurgitation and no significant pericardial effusion. No evidence of 
significant myocardial iron overload based on T2* value.</td></tr>
<tr><td bgcolor="#ababab">Structured</td><td ,="" bgcolor="#ffffff" style="white-space: pre-wrap; word-wrap: break-word;"><table border="1"><tbody><tr><th>CARDIACMRI</th><td>3 Tesla MRI scanner</td></tr><tr><th>CLINICALINFORMATION</th><td>A 65-year-old male with a history of hypertension and dyspnea on exertion. Evaluation for possible hypertrophic cardiomyopathy is requested.</td></tr><tr><th>COMPARISON</th><td><table border="1"><tbody><tr><th>PRIORSTUDYDATE</th><td></td></tr></tbody></table></td></tr><tr><th>FINDINGS</th><td><table border="1"><tbody><tr><th>LEFTVENTRICULARMEASUREMENTS</th><td><table border="1"><tbody><tr><th>ENDDIASTOLICDIAMETER</th><td><table border="1"><tbody><tr><th>VALUE</th><td></td></tr></tbody></table></td></tr><tr><th>EJECTIONFRACTION</th><td><table border="1"><tbody><tr><th>VALUE</th><td>55</td></tr><tr><th>UNIT</th><td>%</td></tr></tbody></table></td></tr><tr><th>STROKEVOLUME</th><td><table border="1"><tbody><tr><th>VALUE</th><td>106</td></tr><tr><th>UNIT</th><td>ml</td></tr></tbody></table></td></tr><tr><th>ENDDIASTOLICVOLUME</th><td><table border="1"><tbody><tr><th>VALUE</th><td>193</td></tr><tr><th>UNIT</th><td>mL</td></tr><tr><th>INDEXED</th><td>89 mL/m2</td></tr></tbody></table></td></tr><tr><th>ENDSYSTOLICVOLUME</th><td><table border="1"><tbody><tr><th>VALUE</th><td>87</td></tr><tr><th>UNIT</th><td>mL</td></tr><tr><th>INDEXED</th><td>40 mL/m2</td></tr></tbody></table></td></tr><tr><th>CARDIACOUTPUT</th><td><table border="1"><tbody><tr><th>VALUE</th><td></td></tr></tbody></table></td></tr><tr><th>CARDIACINDEX</th><td><table border="1"><tbody><tr><th>VALUE</th><td></td></tr></tbody></table></td></tr><tr><th>BODYSURFACEAREA</th><td><table border="1"><tbody><tr><th>VALUE</th><td>2.18</td></tr><tr><th>UNIT</th><td>m2</td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><th>RIGHTVENTRICULARMEASUREMENTS</th><td><table border="1"><tbody><tr><th>ENDDIASTOLICDIAMETER</th><td><table border="1"><tbody><tr><th>VALUE</th><td></td></tr></tbody></table></td></tr><tr><th>EJECTIONFRACTION</th><td><table border="1"><tbody><tr><th>VALUE</th><td>56</td></tr><tr><th>UNIT</th><td>%</td></tr></tbody></table></td></tr><tr><th>STROKEVOLUME</th><td><table border="1"><tbody><tr><th>VALUE</th><td>88</td></tr><tr><th>UNIT</th><td>mL</td></tr><tr><th>INDEXED</th><td>40 mL/m2</td></tr></tbody></table></td></tr><tr><th>ENDDIASTOLICVOLUME</th><td><table border="1"><tbody><tr><th>VALUE</th><td>156</td></tr><tr><th>UNIT</th><td>mL</td></tr><tr><th>INDEXED</th><td>72 mL/m2</td></tr></tbody></table></td></tr><tr><th>ENDSYSTOLICVOLUME</th><td><table border="1"><tbody><tr><th>VALUE</th><td>68</td></tr><tr><th>UNIT</th><td>mL</td></tr><tr><th>INDEXED</th><td>31 mL/m2</td></tr></tbody></table></td></tr><tr><th>CARDIACOUTPUT</th><td><table border="1"><tbody><tr><th>VALUE</th><td></td></tr></tbody></table></td></tr><tr><th>CARDIACINDEX</th><td><table border="1"><tbody><tr><th>VALUE</th><td></td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><th>VALVES</th><td><table border="1"><tbody><tr><th>AORTICVALVE</th><td><table border="1"><tbody><tr><th>AORTICFORWARDVOLUME</th><td><table border="1"><tbody><tr><th>VALUE</th><td></td></tr></tbody></table></td></tr><tr><th>AORTICREGURGITANTVOLUME</th><td><table border="1"><tbody><tr><th>VALUE</th><td>Mild</td></tr><tr><th>UNIT</th><td></td></tr></tbody></table></td></tr><tr><th>AORTICVALVEAREA</th><td><table border="1"><tbody><tr><th>VALUE</th><td></td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><th>MITRALVALVE</th><td></td></tr><tr><th>PULMONICVALVE</th><td></td></tr><tr><th>TRICUSPIDVALVE</th><td></td></tr></tbody></table></td></tr><tr><th>SHUNTINFORMATION</th><td><table border="1"><tbody><tr><th>QPQSRATIO</th><td><table border="1"><tbody><tr><th>VALUE</th><td></td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><th>OTHERFINDINGS</th><td><table border="1"><tbody><tr><th>ASYMMETRICSEPTALHYPERTROPHY</th><td>18 mm in the basal anteroseptal segment</td></tr><tr><th>MYOCARDIALFIBROSIS</th><td>Patchy mid-myocardial enhancement in the hypertrophied septal segments</td></tr><tr><th>MYOCARDIALEDEMAOREDEMA</th><td>None</td></tr><tr><th>MYOCARDIALIRONOVERLOAD</th><td>T2* value of 32 milliseconds</td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><th>IMPRESSION</th><td><table border="1"><tbody><tr><th>GLOBALSYSTOLICLVFUNCTION</th><td><table border="1"><tbody><tr><th>NORMAL</th><td>Preserved left ventricular ejection fraction at 55%</td></tr></tbody></table></td></tr><tr><th>GLOBALSYSTOLICRVFUNCTION</th><td><table border="1"><tbody><tr><th>NORMAL</th><td>Normal right ventricular function</td></tr></tbody></table></td></tr><tr><th>INTRACARDIACSHUNT</th><td><table border="1"><tbody><tr><th>NONE</th><td>None</td></tr></tbody></table></td></tr><tr><th>VALVULARDISEASE</th><td><table border="1"><tbody><tr><th>AORTIC</th><td>Mild aortic regurgitation</td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><th>REFERENCE</th><td>American Journal of Roentgenology. 2014;203: 1265-1271. 10.2214/AJR.14.12636</td></tr></tbody></table></td></tr>
</tbody>
</table>
</body></html>